EUVIMEDEUVIMED entdecken
Open Access

CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models

Xiaojun Hu, Renhan Dong, Sheng Huang, Yisheng Zeng, Wei Zhan, Xiaofang Gao, Dong Tian, Jian Peng, Jiewei Xu, Ting Wang, Yaying Zhang, Xiaohui Wang und 4 weitere

Antimicrobial Agents and Chemotherapy · 17.05.2023 · 67 (5)

DOI: 10.1128/aac.01704-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 17.05.2023. Verfasst von Xiaojun Hu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu Medical College, Chengdu, Sichuan Province, China. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan science and technology program, Chengdu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) causes severe diarrhea and colitis, leading to significant morbidity, mortality, and high medical costs worldwide. Oral vancomycin, a first-line treatment for CDI, is associated with a high risk of recurrence, necessitating novel therapies for primary and recurrent CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsCricetinaeAnimalsMiceVancomycinAnti-Bacterial AgentsRecurrence

Stichwörter der Autor:innen

CDBN-YGXZClostridioides difficile infectiondysbiosishamstermicrobiomemousepyruvate:ferredoxin/flavodoxin oxidoreductasesrelapse/recurrence

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Pharmacy, Chengdu Medical College, Chengdu, Sichuan Province, China.
  • Chengdu Biobel Biotechnology Co., Ltd., Chengdu, Sichuan Province, China.
  • Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

ORCID-Profile: Tai Yang

Förderung

  • National Natural Science Foundation of China
  • Sichuan science and technology program
  • Chengdu Medical College

Zitieren

APA

Hu, X., Dong, R., Huang, S., Zeng, Y., Zhan, W., Gao, X., Tian, D., Peng, J., Xu, J., Wang, T., Zhang, Y., Wang, X., Zhang, X., Liu, J., Guang, B., & Yang, T. (2023). CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models. Antimicrobial Agents and Chemotherapy, 67(5). https://doi.org/10.1128/aac.01704-22

Vancouver

Hu X, Dong R, Huang S, Zeng Y, Zhan W, Gao X, et al. CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models. Antimicrobial Agents and Chemotherapy. 2023;67(5). doi:10.1128/aac.01704-22

BibTeX
@article{Hu2023,
  author = {Hu, Xiaojun and Dong, Renhan and Huang, Sheng and Zeng, Yisheng and Zhan, Wei and Gao, Xiaofang and Tian, Dong and Peng, Jian and Xu, Jiewei and Wang, Ting and Zhang, Yaying and Wang, Xiaohui and Zhang, Xiaoxia and Liu, Jin and Guang, Bing and Yang, Tai},
  title = {CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {5},
  doi = {10.1128/aac.01704-22}
}
Kostenlos starten →